首页> 外文期刊>Diabetes >Functional Investigations of HNF1A Identify Rare Variants as Risk Factors for Type 2 Diabetes in the General Population
【24h】

Functional Investigations of HNF1A Identify Rare Variants as Risk Factors for Type 2 Diabetes in the General Population

机译:HNF1A的功能研究确定罕见变异是普通人群中2型糖尿病的危险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Variants in HNF1A encoding hepatocyte nuclear factor 1α (HNF-1A) are associated with maturity-onset diabetes of the young form 3 (MODY 3) and type 2 diabetes. We investigated whether functional classification of HNF1A rare coding variants can inform models of diabetes risk prediction in the general population by analyzing the effect of 27 HNF1A variants identified in well-phenotyped populations (n = 4,115). Bioinformatics tools classified 11 variants as likely pathogenic and showed no association with diabetes risk (combined minor allele frequency [MAF] 0.22%; odds ratio [OR] 2.02; 95% CI 0.73-5.60; P = 0.18). However, a different set of 11 variants that reduced HNF-1A transcriptional activity to <60% of normal (wild-type) activity was strongly associated with diabetes in the general population (combined MAF 0.22%; OR 5.04; 95% CI 1.99-12.80; P = 0.0007). Our functional investigations indicate that 0.44% of the population cany HNF1A variants that result in a substantially increased risk for developing diabetes. These results suggest that functional characterization of variants within MODY genes may overcome the limitations of bioinformatics tools for the purposes of presymptomatic diabetes risk prediction in the general population.
机译:编码肝细胞核因子1α(HNF-1A)的HNF1A变异与年轻3型(MODY 3)和2型糖尿病的成熟期糖尿病相关。我们调查了HNF1A罕见编码变体的功能分类是否可以通过分析在表型良好的人群(n = 4,115)中鉴定出的27种HNF1A变体的影响来指导普通人群中糖尿病风险预测的模型。生物信息学工具将11个变异体归类为可能的致病性,并且与糖尿病风险无关(合并的次要等位基因频率[MAF] 0.22%;比值比[OR] 2.02; 95%CI 0.73-5.60; P = 0.18)。然而,在普通人群中,一组将HNF-1A转录活性降低至正常(野生型)活性的<60%的11种变体与糖尿病的发生密切相关(MAF为0.22%; OR为5.04; 95%CI为1.99- 12.80; P = 0.0007)。我们的功能研究表明,人口中有0.44%的犬种HNF1A变异导致罹患糖尿病的风险大大增加。这些结果表明,MODY基因内变体的功能表征可以克服生物信息学工具的局限性,从而可以预测一般人群的症状前糖尿病风险。

著录项

  • 来源
    《Diabetes》 |2017年第2期|335-346|共12页
  • 作者单位

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway ,Department of Biomedicine, University of Bergen, Bergen, Norway;

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway;

    Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Department of Pediatrics, Haukeland University Hospital, Bergen, Norway;

    Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway ,Department of Pathology, Haukeland University Hospital, Bergen, Norway;

    Department of Clinical Sciences, Diabetes and Endocrinology, Clinical Research Center, Lund University, Malmoe, Sweden;

    Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA ,Departments of Genetics and Medicine, Harvard Medical School, Boston, MA ,Departments of Molecular Biology and Diabetes Unit, Massachusetts General Hospital, Boston, MA;

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway;

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Department of Biomedical Laboratory Sciences, Bergen University College, Bergen, Norway;

    KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway ,Department of Pediatrics, Haukeland University Hospital, Bergen, Norway;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号